• Pharma’s AI Future

    Dec 12, 2018, 09:55 AM by Michael Croft

    Bio-IT World | The recent AI World Conference & Expo made one thing clear: now is the time for pharma to embrace AI and start realizing some of the benefits other industries are enjoying.

    Full story

  • OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

    Dec 12, 2018, 07:44 AM by Michael Croft
    STOCKHOLM, SWEDEN - Dec 12, 2018 - Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market
    Full story

  • Creative Diagnostics Introduces Cytotoxic Drug Antibodies for Science Community

    Dec 12, 2018, 01:33 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Dec 13, 2018 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics is proud to announce that it has launched a new set of antibodies specific to cytotoxic drugs for life science community facing the growing challenges for scientific research
    Full story

  • Rho Announces New Regulatory Strategy and Submissions Business Segment

    Dec 11, 2018, 09:53 AM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Dec 10, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced a new Regulatory Strategy and Submissions business segment
    Full story

  • FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery with Geneious Biologics

    Dec 10, 2018, 12:29 PM by Michael Croft
    AUCKLAND CITY, NEW ZEALAND - Dec 10, 2018 - AUCKLAND, NZ – December 10, 2018 – Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the company’s growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs
    Full story

  • Rehm Replaces Haussler As GA4GH Vice Chair, Other Changes

    Dec 10, 2018, 12:20 PM by Michael Croft

    Bio-IT World Brief  GA4GH announced several changes in leadership. GA4GH Vice Chair David Haussler, Scientific Director of the University of California Santa Cruz Genomics Institute, will be succeeded by Heidi Rehm,an institute member at the Broad Institute of MIT and Harvard and chief genomics officer at Massachusetts General Hospital. 

    Full story

  • 10x Genomics Acquires Spatial Genomics Company

    Dec 10, 2018, 11:25 AM by Michael Croft
    Bio-IT World Brief   10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.
    Full story

  • Qlucore announces partnership with Cambridge Protein Arrays Ltd

    Dec 10, 2018, 11:12 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Dec 10, 2018 - The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysis
    Full story

  • HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for Cancer

    Dec 10, 2018, 09:13 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Dec 10, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, today announced the formation of Victa Biotherapeutics, a joint venture with Vikas P
    Full story

  • 10x Genomics Acquires Spatial Transcriptomics

    Dec 10, 2018, 08:50 AM by Michael Croft
    PLEASANTON, CA, UNITED STATES - Dec 10, 2018 - 10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics
    Full story

  • Rho Experts Explore Right-to-Try Legislation and Existing Expanded Access Programs in Free Webinar

    Dec 7, 2018, 12:04 PM by Michael Croft
    CHAPEL HILL, NC - Dec 7, 2018 -  Rho Experts Explore Right-to-Try Legislation and ExistingExpanded Access Programs in Free Webinar WHAT:                 The impact of Right-to-Try legislation has been in the news a lot recently, but what does the legislation mean for product sponsors? Rho, a full-service contract research organization (CRO), will explore both Right-to-Try legislation and existing Expanded Access Programs in a new free webinar, including:o   Understanding sponsor responsibilities under these programs and when products may be eligibleo   Evaluating options such as treatment protocols, treatment INDs, and emergency useo   Discussing development risks associated with participation in these programs The webinar, "Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA's Expanded Access," will take place on Tuesday, Dec
    Full story

  • A Mature Capital Structure Positions Bio-IT Startups For Success

    Dec 6, 2018, 11:45 AM by Michael Croft

    Bio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.

    Full story

  • Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity

    Dec 6, 2018, 09:03 AM by Michael Croft
    PLYMOUTH MEETING, PA - Dec 6, 2018 - Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent)
    Full story

  • Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research Centers

    Dec 5, 2018, 14:45 PM by Michael Croft
    RANCHO SANTA MARGARITA, CA, UNITED STATES - Dec 4, 2018 - Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research CentersCutting Edge Data Quality Transforms Real-World Clinical Data into aFuture-Proofed, Research-Ready Data Goldmine for Better Patient CareMelissa, a leading provider of global contact data quality and identity verification solutions, today announced advanced artificial intelligence (AI) solutions that combine machine reasoning, natural language processing, and machine learning to tackle one of healthcare's biggest problems: the time and cost of data harmonization and integration
    Full story

  • Equus Compute Solutions Announces Release of G2660 2U 2xGPU Server

    Dec 5, 2018, 13:47 PM by Michael Croft
    EDINA, MN - Dec 5, 2018 - Equus Compute Solutions announces the release of its new G2660 2U 2xGPU server, ideal for artificial intelligence and deep learning environments
    Full story

  • Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)

    Dec 5, 2018, 11:11 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Dec 5, 2018 - Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry
    Full story

  • GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline

    Dec 5, 2018, 10:39 AM by Michael Croft
    Endpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.
    Full story

  • OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling

    Dec 5, 2018, 09:20 AM by Michael Croft

    Bio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.

    Full story

  • Certara Launches BaseCase Toolkits to Facilitate Pharmaceutical and Medical Device Field Teams’ HCP and Payer Presentations

    Dec 5, 2018, 08:14 AM by Michael Croft
    PRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations
    Full story

  • uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target

    Dec 5, 2018, 05:48 AM by Michael Croft
    EDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target
    Full story